Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $136,206 - $182,224
-230 Reduced 11.45%
1,779 $1.38 Million
Q4 2023

Jan 11, 2024

BUY
$525.19 - $619.13 $77,202 - $91,012
147 Added 7.89%
2,009 $1.17 Million
Q3 2023

Oct 13, 2023

BUY
$434.7 - $599.3 $809,411 - $1.12 Million
1,862 New
1,862 $1 Million
Q1 2023

Apr 17, 2023

SELL
$310.63 - $364.82 $219,304 - $257,562
-706 Reduced 29.1%
1,720 $591,000
Q4 2022

Jan 12, 2023

BUY
$321.55 - $374.67 $213,830 - $249,155
665 Added 37.76%
2,426 $888,000
Q3 2022

Nov 02, 2022

SELL
$296.48 - $337.87 $127,782 - $145,621
-431 Reduced 19.66%
1,761 $569,000
Q2 2022

Aug 08, 2022

BUY
$278.73 - $327.27 $100,342 - $117,817
360 Added 19.65%
2,192 $711,000
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $429,952 - $534,321
1,832 New
1,832 $525,000
Q1 2021

Apr 27, 2021

SELL
$164.32 - $212.72 $497,068 - $643,478
-3,025 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $490,920 - $649,606
-3,763 Reduced 55.44%
3,025 $511,000
Q4 2020

Jan 13, 2021

SELL
$130.46 - $172.63 $222,825 - $294,852
-1,708 Reduced 20.1%
6,788 $1.15 Million
Q3 2020

Nov 02, 2020

BUY
$146.22 - $169.13 $223,862 - $258,938
1,531 Added 21.98%
8,496 $1.26 Million
Q2 2020

Jul 21, 2020

BUY
$136.42 - $164.18 $155,791 - $187,493
1,142 Added 19.61%
6,965 $1.14 Million
Q1 2020

Apr 14, 2020

BUY
$119.05 - $147.35 $471,676 - $583,800
3,962 Added 212.9%
5,823 $808,000
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $198,978 - $246,452
1,861 New
1,861 $245,000
Q3 2019

Nov 15, 2019

SELL
$106.79 - $116.16 $516,116 - $561,401
-4,833 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$110.79 - $129.32 $535,448 - $625,003
4,833 New
4,833 $535,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track One Ascent Financial Services LLC Portfolio

Follow One Ascent Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Ascent Financial Services LLC with notifications on news.